CRS | CERES Regulatory Services

Chemistry, Manufacturing & Controls (CMC)

At CERES Regulatory Services, our role extends to the detailed physicochemical characterization and structure elucidation of your product, providing a solid foundation for your development and regulatory strategy. Our experts ensure thorough documentation of product properties, leveraging state-of-the-art technologies and methodologies to unravel complex molecular structures and interactions. 

CERES Regulatory Services

Expertise in Analytical Development and Validation

CERES Regulatory Services is at the forefront of delivering unparalleled expertise in analytical methods development and validation, offering a comprehensive suite of services designed to ensure your product’s quality assessment is both robust and compliant. With a deep understanding of Chemistry, Manufacturing, and Controls (CMC), our team excels in preparing and aligning CMC sections for global regulatory submissions, meticulously tailored to meet diverse regulatory requirements worldwide. 

Our proficiency extends to the development of sophisticated analytical methods that are not only precise and accurate but also reproducible and robust across various matrices. Our team is skilled in navigating the complex landscape of method validation, ensuring that each method is rigorously tested to meet international standards and regulatory expectations for specificity, sensitivity, linearity, accuracy, and precision. 

Innovative Strategic Regulatory Services Designed to Achieve First Cycle Approvals & Rescue from Regulatory Challenges
Expertise in Regulatory Landscape
CERES Regulatory Services

Designing Stability Studies for Product Robustness

CERES Regulatory Services specializes in designing comprehensive stability studies that meticulously demonstrate your product’s robustness and predict its shelf life. Our strategic approach to stability testing encompasses real-time, accelerated, and stress conditions, ensuring a thorough understanding of product stability under diverse environmental factors. 

CERES Regulatory Services

Physicochemical Characterization and Structure Elucidation

Our role extends to the detailed physicochemical characterization and structure elucidation of your product, providing a solid foundation for your development and regulatory strategy. Our experts ensure thorough documentation of product properties, leveraging state-of-the-art technologies and methodologies to unravel complex molecular structures and interactions. 

Expertise in Regulatory Landscape
Consultants We offer strategic
CERES Regulatory Services

Efficient and Compliant Manufacturing Processes

We understand the critical importance of scalable and compliant manufacturing processes in the success of your product. Our team offers strategic insights into process optimization, ensuring efficiency, scalability, and compliance with regulatory standards. We support the preparation of Drug Master Files (DMFs) and handle global submissions, including EDMF, CDMF, IND, NDS, and Certificate of Suitability, with precision and expertise. 

 

CERES Regulatory Services

Comprehensive Post-Approval Support

Beyond initial approval, CERES Regulatory Services provides ongoing post-approval support, including the preparation of Annual Reports, Prior Approval Supplements (PAS), Changes Being Effected (CBE) supplements, and Type I and II variations. Our commitment to your product’s lifecycle ensures continuous compliance and adaptability to regulatory changes. 

Innovative Products
Our experience supporting hundreds
CERES Regulatory Services

Innovative Pre-Formulation and Formulation Optimization

Our involvement spans pre-formulation studies and formulation optimization, employing cutting-edge technologies and methodologies to enhance product efficacy, stability, and patient compliance. Our development reports are meticulously prepared, offering detailed insights into formulation strategies and outcomes. 

 

CERES Regulatory Services

Process Validation and Report Preparation

We excel in designing and executing process validation studies, providing comprehensive documentation that meets regulatory scrutiny. Our approach ensures that your manufacturing processes are not only efficient but also reproducible and compliant with regulatory standards, paving the way for successful product commercialization. 

regulatory expectations.
strategies for improving patient access
CERES Regulatory Services

Why Choose CERES Regulatory Services?

Choosing CERES Regulatory Services means partnering with a team of experts whose commitment to quality, compliance, and innovation sets them apart as the premier choice for regulatory CMC consulting services. Our tailored approach, combined with our extensive experience and global expertise, ensures that your product not only meets regulatory requirements but also exceeds them, facilitating a smoother path to market approval and commercial success. 

At CERES Regulatory Services, we’re not just consultants; we’re your strategic partners in achieving excellence. Let us navigate the complex regulatory landscape together, transforming challenges into opportunities and ensuring your product’s quality, efficacy, and safety stand the test of time. 

 

CERES Regulatory Services

Market Insight

regulatory expectations.
strategies for improving patient access
CERES Regulatory Services

Formulation Development

CERES Regulatory Services

CMC Updates

Data generated during the development of a drug substance, drug intermediate or drug product on the chemistry (identification, characterisation, development) manufacturing (process flow, process description), and quality controls (specifications, test methods, stability) form the Chemistry, Manufacturing and Controls (CMC) component of the regulatory submission. Note that such details may form a component of any of the following submissions: IND, NDA, ANDA or DMF. The CMC section of a dossier provides evidence of the controls put in place to assure the quality of the product be it a drug substance, intermediate or drug product. FDA current thinking is that quality should be built into the product, and testing alone cannot be relied on to ensure product quality. As such, FDA inspections a more process and system, than product focused. 

regulatory expectations.
strategies for improving patient access
CERES Regulatory Services

CMC Updates

Details provided in the CMC section of a dossier are broadly divided into the following areas for Drug Substance: 

CERES Regulatory Services

CMC Updates

Details provided in the CMC section of a dossier are broadly divided into the following areas for Drug Product: 

regulatory expectations.

Quick Support

Get in Touch Today!

Proactively deliver seamless core competencies with scalable. Completely fabricate transparent paradigms.

Call Us

Questions about our product or pricing? Call for support

Email Us

Our support will help you Monday to Saturday

Tell Us About Your Project

Fill out the form and we'll be in touch ASAP.